ArticleDrug design, development and therapy2026

For Advanced Oesophageal Squamous Cell Carcinoma, PD-1 Antibody Combined with Chemotherapy Improves Progression-Free Survival Compared with Monotherapy or Chemotherapy Alone as First-Line Treatment: A Retrospective Study with Prognostic Biomarker Analysis.

Feng Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.